Liven Pharma Limited engages in the manufacture and sale of pharmaceutical products in Pakistan. It provides products for various therapeutic areas, such as alpha-1 adrenergic blocker; analgesic; anelgesic; antianaerobic; antianemic; antibiot; antibiotic; antiboitic; antiemetic; antiepileptic; antifungal; antihistamine; antimalarial; antiprotozoal; antipsychotic; antipyretic; antispasmodic; antiviral; intestinal adsorbents; muscle relaxant; narcotic analgesic; NSAID; oral analgesic; proton pump inhibitor; psyllium; sedative; sedative-hpnotic; s... [
LIVEN — Liven Pharma Limited
Sector: Pharmaceuticals · Pakistan Stock Exchange
⚠ Prices: 6 Nov 2026 — PSX end-of-day close (feed fetched 23:14 PKT) · Fundamentals: public data collected 6 Nov 2026 · Not live prices.Summary — LIVEN
| Measure | Value |
|---|---|
| Price (Rs, 6 Nov — PSX delayed feed) | 31.47 |
| Change, 6 Nov session (delayed) | -4.35% |
| Volume (shares, 6 Nov session) | 51,636 |
| Market capitalisation | Rs 3.56 bn |
| Revenue (TTM) | Rs 111.3 mn |
| Price / Earnings (P/E) | — |
| Price / Book (P/B) | 3.33 |
| Dividend yield | 0.00% |
| Return on equity (ROE) | -3.80% |
| Net margin | -29.40% |
| Debt / Equity (as reported by source) | 3.40% |
| Revenue growth, 3-year | — |
Company Snapshot
| Paid-up Capital | Rs 1,130.40 mn |
| Authorized Capital | Rs 1,200.00 mn |
| Shares Outstanding | 113.04 mn |
| Free Float | 11.30 mn |
| Free Float % | 10.00 % |
| Face Value | Rs 10.00 |
| Fiscal Year End | June |
| Avg Volume (12M) | 142,654 |
| Book Value / Share | Rs. 7.32 (Upto 2026 3Q) |
| Total Book Value (computed) | Rs 827.5 mn |
Capital data: SCSTRADE company snapshot, collected 6 Nov 2026. Total Book Value is computed on this page as Book Value / Share × Shares Outstanding.
PSX Scorecard — five checks on this stock's own data
VALUE
0/6
FUTURENo forecast data
PAST
0/6
HEALTH
3/6
DIVIDEND
0/6
Strongest: Financial health (3/6). Weakest: Value (0/6).
How this is scored
Scores are computed mechanically from the data on this page, 0–6 per axis, scaled over the checks that could be run — an axis with no data is labelled, never scored zero for missing data. VALUE: upside to the average analyst target (bands from +30% down), P/E and P/B below the sector median, yield above the sector median. FUTURE: S&P consensus forward EPS and revenue growth bands (only where estimates exist). PAST: revenue and EPS growth across the published financial history, latest year profitable, ROE bands. HEALTH: debt/equity bands, positive latest net margin, no loss-making year in the history. DIVIDEND: yield bands, years of recorded DPS, DPS trend, and payout (DPS ÷ EPS) at or under 100%. The full rule table is in the site's data inventory. Scores are a data summary, not a recommendation.
Performance — LIVEN
Day range — 6 Nov 2026 session
Day lowRs 31.11Close Rs 31.47Day highRs 33.30
Day high/low from the official PSX market-summary feed for the 6 Nov 2026 session.
Investment Case — LIVEN
Strengths — from the numbers
- Net margin of -29.43% in the latest published year, FY2026.
- Debt/equity of 0.03 — below 1 (the source reports this figure as 3.40%).
Risks / watch points — from the numbers
- Revenue fell -16.9% in the latest year, FY2026 (Rs 127m → Rs 106m).
- Earnings per share fell -96.1% in the latest year, FY2026 (Rs -7.11 → Rs -0.28).
- Loss-making in FY2026: net income was Rs -31m.
- Loss-making in FY2025: net income was Rs -584m.
- Loss-making in FY2023: net income was Rs -12m.
- Loss-making in FY2022: net income was Rs -14m.
Recent performance — FY2026
| Revenue | Rs 106m (-16.9% vs FY2025) |
| Net income | Rs -31m (-94.7% vs FY2025) |
| EPS | Rs -0.28 (-96.1% vs FY2025) |
| Net margin | -29.43% |
Latest published fiscal year from the financial history below (StockAnalysis figures, collected 6 Nov 2026).
Generated from the figures above — PSX Analysis data summary, not investment advice.
Quotes — LIVEN
| Quote | Value |
|---|---|
| Last price (Rs) | 31.47 |
| Change, 6 Nov session | -4.35% |
| Day open, 6 Nov (Rs) | 32.00 |
| Day high, 6 Nov (Rs) | 33.30 |
| Day low, 6 Nov (Rs) | 31.11 |
| Previous close — LDCP (Rs) | 32.90 |
| Volume (shares, 6 Nov session) | 51,636 |
| Market capitalisation | Rs 3.56 bn |
Day open/high/low and previous close (LDCP) are from the official PSX market-summary feed for the 6 Nov 2026 session, the same feed that supplies the closing price. 1-year figures are computed from the daily-close chart series below.
Technicals — LIVEN
Classic pivot levels — from the 6 Nov session
| Level | Rs |
|---|---|
| Resistance 2 (R2) | 34.15 |
| Resistance 1 (R1) | 32.81 |
| Pivot point (PP) | 31.96 |
| Support 1 (S1) | 30.62 |
| Support 2 (S2) | 29.77 |
Classic pivots from the 6 Nov 2026 session's high (Rs 33.30), low (Rs 31.11) and close (Rs 31.47) in the official PSX feed. The close sits below the pivot point.
Technicals are mechanical calculations on past prices. They describe momentum and recent trading ranges only — not investment advice.
Company — LIVEN
| Company | Liven Pharma Limited |
| Symbol | LIVEN |
| Sector | Pharmaceuticals |
| Market capitalisation | Rs 3.56 bn |
| Revenue (TTM) | Rs 111.3 mn |
Founded 1991 · Employees 39 — as published by StockAnalysis.
Company description: StockAnalysis company profile, collected 6 Nov 2026.
Exchange record: PSX company profile for LIVEN (Pakistan Stock Exchange data portal).
Financials — LIVEN
Revenue (TTM)
Rs 111m
Rs 111m
Net income (TTM)
Rs -8m
Rs -8m
EPS (TTM)
Rs -0.08
Rs -0.08
Net margin (TTM)
-7.51%
-7.51%
P/B
3.33
3.33
Dividend yield
0.00%
0.00%
ROE
-3.80%
-3.80%
Net margin
-29.40%
-29.40%
Debt / Equity
3.40%
3.40%
| Measure | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue (Rs m) | — | — | 245 | 127 | 106 |
| Operating income (Rs m) | -18 | -15 | 42 | -492 | -76 |
| Net income (Rs m) | -14 | -12 | 42 | -584 | -31 |
| EPS (Rs) | -1.18 | -1.02 | 1,043.60 | -7.11 | -0.28 |
| Net margin | — | — | 17.03% | -459.22% | -29.43% |
Trailing twelve months (to Sep 30, 2026, not a completed fiscal year): Revenue Rs 111m · Net income Rs -8m · EPS Rs -0.08 · Net margin -7.51%.
Source: StockAnalysis financials, collected 6 Nov 2026 — this stock's published history here spans FY2022–FY2026 (5 fiscal years; the source table publishes a maximum of five completed years per stock). A dash means the source did not publish that figure for that year.
Valuation & Fair Value — LIVEN
Fair P/E Value — sector multiple
Fair P/E not meaningful — earnings are negative.
EPS (TTM) is Rs -0.08, so a P/E multiple cannot produce a meaningful fair price for this stock and no value is shown for this measure.
Fair P/B Value — sector multiple
Rs 21.52
Current price Rs 31.47 · -31.6%
Formula: sector median P/B 2.94× × book value per share Rs 7.32 = Rs 21.52. Sector median across 11 Pharmaceuticals peers with a published P/B — the same basis as the median table below. Book value per share from the SCSTRADE company snapshot (Upto 2026 3Q), collected 6 Nov 2026.
Each measure stands on its own stated basis — they are deliberately not blended into a single fair value. Mechanical estimates computed from published data; not investment advice.
| Measure | LIVEN | Sector median |
|---|---|---|
| Price / Book (P/B) | 3.33 | 2.94 |
| Dividend yield | 0.00% | 1.50% |
| Return on equity (ROE) | -3.80% | 21.65% |
Sector median across 14 listed peers in our dataset (sector: Pharmaceuticals), computed only from peers where the measure is published; a median is shown only when at least 5 peers have the measure.
Sector — LIVEN
LIVEN ranks #14 by market capitalisation among the 14 listed Pharmaceuticals stocks in our dataset. Full sector tables: Sectors.
FAQ — LIVEN
What is the current LIVEN share price?
Liven Pharma Limited (LIVEN) last traded at Rs 31.47 in the 6 Nov 2026 session, -4.35% on the day. Prices on this page are the PSX end-of-day close from the official delayed feed, not live prices.
Which PSX sector is LIVEN in?
Liven Pharma Limited (LIVEN) is classified in the Pharmaceuticals sector on the Pakistan Stock Exchange.
What are LIVEN's P/E ratio and dividend yield?
Liven Pharma Limited (LIVEN) shows a dividend yield of 0.00% in the public data collected 6 Nov 2026.
Answers are generated from this page's own figures (public data collected 6 Nov 2026; prices are the 6 Nov 2026 PSX end-of-day close, not live).
Liven Pharma Limited (LIVEN) is classified in the Pharmaceuticals sector on the Pakistan Stock Exchange.
Every figure above comes from public listings collected on 6 November 2026 (StockAnalysis and SmartMoney, merged by symbol), with the price, change and volume refreshed on 6 Nov 2026 from the official PSX delayed market feed (end-of-day close, fetched 23:14 PKT) — delayed figures, not live prices. If this stock was absent from that feed, its price is the previous latest close. A dash means the measure was not published for this stock by the sources, not that it is zero. Compare LIVEN with the market's largest shares in the Top 250 screener, browse the whole market in Stocks A–Z, and read the ratios explainer in Learn.
This page is a data summary for education, not a recommendation to buy or sell LIVEN.